Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection

University of California, San Diego

Overview

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection.

20 patients with cervicocephalic arterial dissection will be randomized to open-label aspirin or warfarin, rate of stroke and adverse events will be endpoints.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Ischemic Stroke

Interventions

aspirinDRUG

warfarinDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical and imaging diagnosis of cervicocephalic arterial dissection within 3 months. Exclusion Criteria: * Any contraindication to aspirin or warfarin.

Locations (1)

UCSD Medical Center

San Diego, California, United States

Outcomes

Primary Outcomes

Incidence of stroke by one year.

Time frame: 1 year

Secondary Outcomes

Recurrent dissection by one year.

Time frame: 1 year

Incidence of TIA by one year.

Time frame: 1 year

Incidence of major and minor bleeding episodes by one year.

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.